CCRM, a global public-private partnership headquartered in Canada, is funded by the Government of Canada, the Province of Ontario, and leading academic and industry partners. It supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. CCRM has a 40,000 square foot space dedicated to advanced cell manufacturing that includes a GMP facility for producing cells and viral vectors. CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients. CCRM is the commercialization partner of OIRM and University of Toronto’s Medicine by Design.